Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 3 of 25

  1. Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has proven to be effective and safe as maintenance therapy and multiline therapy in ovarian cancer, especially in patients with BRCA mutations. ... efficac...

    Authors: Jing Ni, Rui Zhou, Xianzhong Cheng, Xia Xu, Wenwen Guo and Xiaoxiang Chen
    Citation: Journal of Ovarian Research 2020 13:29
  2. Ovarian cancer (OC) is one of the most aggressive women cancers with increasing incidence and mortality rates worldwide. ... demonstrated play an important roles in a many cancers, the detailed function and mecha...

    Authors: Xiaolei Yuan, Ying Huang, Man Guo, Xiaowei Hu and Peiling Li
    Citation: Journal of Ovarian Research 2021 14:6
  3. The HOX genes are a family of homeodomain-containing transcription factors that determine cellular identity during development. Here we review a number of recent studies showing that HOX genes are strongly expres...

    Authors: Zoë L Kelly, Agnieszka Michael, Simon Butler-Manuel, Hardev S Pandha and Richard GL Morgan
    Citation: Journal of Ovarian Research 2011 4:16
  4. There is no information in the literature on the impact of changes in quality of life (QoL) scores on prognosis in ovarian cancer. We investigated whether changes in QoL during treatment could predict survival in...

    Authors: Digant Gupta, Donald P Braun, Edgar D Staren and Maurie Markman
    Citation: Journal of Ovarian Research 2013 6:17
  5. About 5–10% of all ovarian cancer cases show familial clustering, and some 15–25% of familial ovarian cancer cases are mediated by high-penetrance mutations...BRCA1 and BRCA2...genes. Only few other genes have be...

    Authors: D. S. Prokofyeva, E. T. Mingazheva, Ya. V. Valova, D. D. Sakaeva, R. R. Faishanova, A. Kh. Nurgalieva, R. R. Valiev, N. Bogdanova, T. Dörk and E. K. Khusnutdinova
    Citation: Journal of Ovarian Research 2023 16:66
  6. In this study, we tested the hypothesis that single nucleotide polymorphisms (SNPs) of differentiation-associated human gene icb-1 (C1orf38) may be associated with ovarian cancer susceptibility. For this purpose,...

    Authors: Susanne Schüler, Claus Lattrich, Maciej Skrzypczak, Tanja Fehm, Olaf Ortmann and Oliver Treeck
    Citation: Journal of Ovarian Research 2014 7:42
  7. Fertility preservation using ovarian tissue cryopreservation (OTC) in patients with certain diseases, especially those needing chemo- or radiotherapy, is becoming routine in various Western countries. Our hospita...

    Authors: Jiaojiao Cheng, Xiangyan Ruan, Juan Du, Fengyu Jin, Yanglu Li, Xiaowei Liu, Husheng Wang, Muqing Gu and Alfred O. Mueck
    Citation: Journal of Ovarian Research 2021 14:176
  8. Glutathione peroxidase 3 (GPX3) is a selenocysteine-containing antioxidant enzyme that reacts with hydrogen peroxide and soluble fatty acid hydroperoxides, thereby helping to maintain redox balance within cells. ...

    Authors: Deep Agnani, Olga Camacho-Vanegas, Catalina Camacho, Shashi Lele, Kunle Odunsi, Samantha Cohen, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2011 4:18
  9. Pegylated liposomal doxorubicin (PLD) is a nano-doxorubicin anticancer agent. It was used as early as 2014 to treat ovarian and breast cancer, multiple myeloma and Kaposi's sarcoma. The 2018 National Comprehensiv...

    Authors: Xin-Ru Li, Xing-Han Cheng, Guo-Nan Zhang, Xiao-Xin Wang and Jian-Ming Huang
    Citation: Journal of Ovarian Research 2022 15:96
  10. Karyopherin α-2 (KPNA2) is a member of karyopherin family, which is proved to be responsible for the import or export of cargo proteins. Studies have determined that KPNA2 is associated with the development and p...

    Authors: Xiangrong Cui, Honghong Wang, Xueqing Wu, Kai Huo and Xuan Jing
    Citation: Journal of Ovarian Research 2021 14:71
  11. Ovarian cancer is one of the most common gynecological ... fairly high. However, the pathogenesis of ovarian cancer is not clear. The present study aimed ... expressed genes and signaling pathways associated with...

    Authors: Cuicui Dong, Xin Tian, Fucheng He, Jiayi Zhang, Xiaojian Cui, Qin He, Ping Si and Yongming Shen
    Citation: Journal of Ovarian Research 2021 14:92
  12. Drug resistance and recurrence are main contributors to the poor prognosis of ovarian cancer. Cisplatin is a platinum compound which is ... the treatment of various solid tumors including ovarian cancer. Up to no...

    Authors: Yixuan Liu, Keyu Zhu, Xiaolin Guan, Suhong Xie, Yanchun Wang, Ying Tong, Lin Guo, Hui Zheng and Renquan Lu
    Citation: Journal of Ovarian Research 2021 14:128
  13. MicroRNAs (miRNAs) are non-coding, single-stranded small RNAs that regulate gene expression negatively, which is involved in fundamental cellular processes. In this study, we investigated the role of miR-490-3P i...

    Authors: Shuo Chen, Xi Chen, Yin-Ling Xiu, Kai-Xuan Sun, Zhi-Hong Zong and Yang Zhao
    Citation: Journal of Ovarian Research 2014 7:84

    The Erratum to this article has been published in Journal of Ovarian Research 2015 8:79

  14. Endometrioid carcinoma of the ovary is one of the most types of epithelial ovarian cancer associated to endometrioisis. Endometrioid tumors as well ... ) in the most common subtypes of ovarian cancer cells compar...

    Authors: Mamadou Keita, Paul Bessette, Manuella Pelmus, Youssef Ainmelk and Aziz Aris
    Citation: Journal of Ovarian Research 2010 3:3
  15. Cervical cancer is one of the most common female ... were obtained using data from GTEx and The Cancer Genome Atlas (TCGA) database. The functionalities ... that were associated with the prognosis of cervical cancer

    Authors: Hengyu Chen, Qingchun Deng, Wenwen Wang, Huishan Tao and Ying Gao
    Citation: Journal of Ovarian Research 2020 13:131
  16. To investigate the alterations of peripheral lymphocyte subpopulations in ovarian cancer patients compared to benign or borderline counterparts....

    Authors: Shuang Ye, Wei Chen, Yuwei Zheng, Yutuan Wu, Libing Xiang, Teng Li, Bo Ping, Xiaoming Zhang and Huijuan Yang
    Citation: Journal of Ovarian Research 2022 15:43
  17. A diagnosis of advanced ovarian cancer is the beginning of a long and ... half of the individuals undergoing therapy for advanced cancer will succumb to the disease, or consequences ... -fluorouracil, and doxorub...

    Authors: Kellie S Rath, Georgia A McCann, David E Cohn, Brian K Rivera, Periannan Kuppusamy and Karuppaiyah Selvendiran
    Citation: Journal of Ovarian Research 2013 6:35
  18. Ovarian cancer is a common malignant tumor in women, ... causes, pathogenesis, recurrence and metastasis of ovarian cancer, and early diagnosis and treatment still face ... . The sensitivity and specificity of ex...

    Authors: Li-hui Si, Guang-chao Sun, Zi-wei Liu, Shi-yu Gu, Chu-han Yan, Jin-yuan Xu and Yan Jia
    Citation: Journal of Ovarian Research 2024 17:126
  19. A leading theory for ovarian carcinogenesis proposes that inflammation associated with incessant ovulation is a driver of oncogenesis. Consistent with this theory, nonsteroidal anti-inflammatory drugs (NSAIDs) ex...

    Authors: Rebecca M. Borneman, Elaine Gavin, Alla Musiyenko, Wito Richter, Kevin J. Lee, David K. Crossman, Joel F. Andrews, Annelise M. Wilhite, Steven McClellan, Ileana Aragon, Antonio B. Ward, Xi Chen, Adam B. Keeton, Kristy Berry, Gary A. Piazza, Jennifer M. Scalici…
    Citation: Journal of Ovarian Research 2022 15:120
  20. Ovarian cancer is the fifth most common cause of cancer death in women and the leading cause ... initiating events and early developmental stages of ovarian cancer, lack of reliable ovarian cancer-specific biomar...

    Authors: Francis Jacob, Sheri Nixdorf, Neville F Hacker and Viola A Heinzelmann-Schwarz
    Citation: Journal of Ovarian Research 2014 7:60
  21. Individual patients with ovarian cancer show remarkably different prognosis. Present prognostic models for ovarian cancer mainly focus on clinico-pathological parameters, so ... are urgently needed. Platelets con...

    Authors: Hao Wang, Yin-hai Xu and Yi Guo
    Citation: Journal of Ovarian Research 2024 17:50
  22. New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as ... 1 (LRG1) in ...

    Authors: John D Andersen, Kristin LM Boylan, Ronald Jemmerson, Melissa A Geller, Benjamin Misemer, Katherine M Harrington, Starchild Weivoda, Bruce A Witthuhn, Peter Argenta, Rachel Isaksson Vogel and Amy PN Skubitz
    Citation: Journal of Ovarian Research 2010 3:21
  23. Autophagy is a lysosomal-driven catabolic process that contributes to preserve cell and tissue homeostases through the regular elimination of damaged, aged and redundant self-constituents. In normal cells, autoph...

    Authors: Claudia Peracchio, Oscar Alabiso, Guido Valente and Ciro Isidoro
    Citation: Journal of Ovarian Research 2012 5:22
  24. Recently, increasing evidence has indicated that elevation of Hexokinase 2 (HK2) plays an important role in several cancers on regulating cell motility and growth. However ... role on regulating cell EMT in human...

    Authors: Xueye Tian, Dan Liu, Xiaohang Zuo, Xiaoli Sun, Mengmin Wu, Xu Li and Yue Teng
    Citation: Journal of Ovarian Research 2022 15:92
  25. Ovarian cancer is the most lethal gynecologic neoplasm, and ... the promising immunotherapy showed limited efficacy in ovarian cancer, probably due to the immunosuppressive microenvironment. ... the immune exclus...

    Authors: Ming Du, Qingqing Cai, Jiaan Sun, Mingxing Zhang, Shuo Zhang, Xiaoxia Liu, Mengyu Zhang and Xiaoyan Zhang
    Citation: Journal of Ovarian Research 2024 17:30
  26. The most frequently used molecular imaging technique is currently 18F-deoxy-glucose (FDG) positron emission tomography (PET). FDG-PET holds promise in the evaluation of recurrent or residual ovarian cancer when C...

    Authors: Yoshio Yoshida, Tetsuji Kurokawa, Tetuya Tsujikawa, Hidehiko Okazawa and Fumikazu Kotsuji
    Citation: Journal of Ovarian Research 2009 2:7
  27. Ubiquitin-binding enzyme E2T (UBE2T), a member of the E2 family of the ubiquitin–proteasome pathway, is associated with tumorigenesis of varioustumours; however, its role and mechanism in ovarian cancer remain un...

    Authors: Ping Cui, Hao Li, Can Wang, Yuan Liu, Mengjun Zhang, Yue Yin, Zhenxing Sun, Yiru Wang and Xiuwei Chen
    Citation: Journal of Ovarian Research 2022 15:103
  28. It is known that the new membrane-bound estrogen receptor GPER-1 acts suppressive in breast cancer cells and its expression decreases during disease ... to evaluate the GPER-1 expression in ovarian cancer and its...

    Authors: Tanja Ignatov, Saskia Modl, Maike Thulig, Christine Weißenborn, Oliver Treeck, Olaf Ortmann, AC Zenclussen, Serban Dan Costa, Thomas Kalinski and Atanas Ignatov
    Citation: Journal of Ovarian Research 2013 6:51
  29. The five-year overall survival (OS) of advanced-stage ovarian cancer remains nearly 25-35%, although several ... heterogeneity and complexity has been seen in ovarian cancer. This study aimed to establish gene si...

    Authors: Akash Pawar, Oindrila Roy Chowdhury, Ruby Chauhan, Sanjay Talole and Atanu Bhattacharjee
    Citation: Journal of Ovarian Research 2022 15:12
  30. Gynecologic cancers comprise malignancies in the female reproductive organs. Ovarian cancer ranks sixth in terms of incidence rates ... mortality rates. The stage at which ovarian cancer is diagnosed mainly deter...

    Authors: Khushbukhat Khan, Sameen Zafar, Yasmin Badshah, Naeem Mahmood Ashraf, Mehak Rafiq, Lubna Danish, Maria Shabbir, Janeen H. Trembley, Tayyaba Afsar, Ali Almajwal and Suhail Razak
    Citation: Journal of Ovarian Research 2023 16:202
  31. Ovarian epithelial tumors are an hallmark of hereditary cancer syndromes which are related to the germ-line inheritance of cancer predisposing mutations in BRCA1 and BRCA2 genes. ... 2-related as compared to "spo...

    Authors: Pierosandro Tagliaferri, Monica Ventura, Francesco Baudi, Iole Cucinotto, Mariamena Arbitrio, Maria Teresa Di Martino and Pierfrancesco Tassone
    Citation: Journal of Ovarian Research 2009 2:14
  32. As a kind of gynecological tumor, ovarian cancer is not as common as cervical cancer and breast cancer, but its malignant degree is higher. Despite the increasingly mature treatment of ovarian cancer, the five-ye...

    Authors: Yongsong Wu, Shilin Xu, Shanshan Cheng, Jiani Yang and Yu Wang
    Citation: Journal of Ovarian Research 2023 16:6
  33. Detailed epidemiologic descriptions of large populations of advanced stage ovarian cancer patients have been lacking to date. This ... in a large cohort of advanced stage ovarian cancer patients in the United Sta...

    Authors: Daniel C. Beachler, Francois-Xavier Lamy, Leo Russo, Devon H. Taylor, Jade Dinh, Ruihua Yin, Aziza Jamal-Allial, Samuel Dychter, Stephan Lanes and Patrice Verpillat
    Citation: Journal of Ovarian Research 2020 13:101
  34. MTHFD2 is a folate-coupled metabolic enzyme, which has been proved to participant in the metabolic reprogramming and tumor cell-sustaining proliferative capacity. However, the function of MTHFD2 in the developmen...

    Authors: Xiangrong Cui, Huancheng Su, Jiaolin Yang, Xueqing Wu, Kai Huo, Xuan Jing and Sanyuan Zhang
    Citation: Journal of Ovarian Research 2022 15:23
  35. Cervical cancer is considered as an important malignancy among women worldwide. Currently-used treatments of cervical cancer are reported to be cytotoxic for patients. ... affect the lives of women suffering from...

    Authors: Moghaddaseh Jahanshahi, Parisa Maleki Dana, Bita Badehnoosh, Zatollah Asemi, Jamal Hallajzadeh, Mohammad Ali Mansournia, Bahman Yousefi, Bahram Moazzami and Shahla Chaichian
    Citation: Journal of Ovarian Research 2020 13:68
  36. Ovarian cancer is the leading cause of cancer-related death among women. Complete cytoreductive surgery ... drug, metformin, has cytotoxic activity in different cancer models. However, the synergism of metformin ...

    Authors: Kuo-Chang Wen, Pi-Lin Sung, Alexander T. H. Wu, Ping-Chieh Chou, Jun-Hung Lin, Chi-Ying F. Huang, Sai-Ching J. Yeung and Mong-Hong Lee
    Citation: Journal of Ovarian Research 2020 13:95
  37. The mortality rate of epithelial ovarian cancer (EOC) remains the first in malignant ... extensive implanted metastasis, and treatment resistance of cancer cells require an extensive metabolism rewiring during th...

    Authors: Ming Wang, Jingjing Zhang and Yumei Wu
    Citation: Journal of Ovarian Research 2023 16:108
  38. Ovarian cancer is the fifth most common cancer among women and causes more deaths than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is based on the combination of surgery a...

    Authors: Mohd Saif Zaman, Diane M Maher, Sheema Khan, Meena Jaggi and Subhash C Chauhan
    Citation: Journal of Ovarian Research 2012 5:44

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.